Adiponectin regulates SR Ca2+ cycling following ischemia/reperfusion via sphingosine 1-phosphate-CaMKII signaling in mice

被引:30
作者
Yan, Wenjun [1 ]
Zhang, Fuyang [1 ]
Zhang, Ronghuai [1 ]
Zhang, Xing [3 ]
Wang, Yanru [4 ]
Zhou, Fen [1 ]
Xia, Yunlong [1 ]
Liu, Peilin [1 ]
Gao, Chao [1 ]
Wang, Han [1 ]
Zhang, Lijian [1 ]
Zhou, Jingjun [3 ]
Gao, Feng [3 ]
Gao, Erhe [5 ]
Koch, Walter J. [5 ]
Wang, Haichang [1 ]
Cheng, Heping [4 ]
Qu, Yan [2 ]
Tao, Ling [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Sch Basic Med Sci, Dept Physiol, Xian 710032, Peoples R China
[4] Peking Univ, Inst Mol Med, Beijing 100083, Peoples R China
[5] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19107 USA
关键词
Adiponectin; Myocardial ischetnia/reperfusion; Sphingosine; 1-phosphate; SERCA2; SARCOPLASMIC-RETICULUM; PROTEIN-KINASE; PLASMA-CONCENTRATIONS; INTERMITTENT HYPOXIA; CARDIAC-FUNCTION; CARDIOPROTECTION; REPERFUSION; INJURY; ISCHEMIA; RECEPTOR;
D O I
10.1016/j.yjmcc.2014.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The adipocyte-secreted hormone adiponectin (APN) exerts protective effects on the heart under stress conditions. Recent studies have demonstrated that APN induces a marked Ca2+ influx in skeletal muscle. However, whether APN modulates [Ca2+](i) activity, especially [Ca2+](i) transients in cardiomyocytes, is still unknown. This study was designed to determine whether APN modulates [Ca2+](i) transients in cardiomyocytes. Adult male wild-type (WT) and APN knockout (APN KO) mice were subjected to myocardial ischemia/reperfusion (I/R, 30 min/30 min) injury. CaMKII-PLB phosphorylation and SR Ca2+-ATPase (SERCA2) activity were downregulated in I/R hearts of WF mice and further decreased in those of APN KO mice. Both the globular domain of APN and full-length APN significantly reversed the decrease in CaMKII-PLB phosphorylation and SERCA2 activity in WT and APN KO mice. Interestingly, compared with WT littermates, single myocytes isolated from APN KO mice had remarkably decreased [Ca2+](i) transients, cell shortening, and a prolonged Ca2+ decay rate. Further examination revealed that APN enhances SERCA2 activity via CaMKII-PLB signaling. In in vivo and in vitro experiments, both APN receptor 1/2 and SIP were necessary for the APN-stimulated CaMKII-PLB-SERCA2 activation. In addition, SIP activated CaMKII-PLB signaling in neonatal cardiomyocytes in a dose dependent manner and improved [Ca2+](i) transients in APN KO myocytes via the SIP receptor (S1PR1/3). Further in vivo experiments revealed that pharmacological inhibition of S1PR1/3 and SERCA2 siRNA suppressed APN-mediated cardioprotection during I/R. These data demonstrate that SIP is a novel regulator of SERCA2 that activates CaMKII-PLB signaling and mediates APN-induced cardioprotection. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 44 条
[1]   Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2+ storage [J].
Abdallah, Yaser ;
Gkatzoflia, Anna ;
Gligorievski, Dragan ;
Kasseckert, Sascha ;
Euler, Gerhild ;
Schlueter, Klaus-Dieter ;
Schaefer, Matthias ;
Piper, Hans-Michael ;
Schaefer, Claudia .
CARDIOVASCULAR RESEARCH, 2006, 70 (02) :346-353
[2]   Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure [J].
Ai, X ;
Curran, JW ;
Shannon, TR ;
Bers, DM ;
Pogwizd, SM .
CIRCULATION RESEARCH, 2005, 97 (12) :1314-1322
[3]   MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death [J].
Aurora, Arin B. ;
Mahmoud, Ahmed I. ;
Luo, Xiang ;
Johnson, Brett A. ;
van Rooij, Eva ;
Matsuzaki, Satoshi ;
Humphries, Kenneth M. ;
Hill, Joseph A. ;
Bassel-Duby, Rhonda ;
Sadek, Hesham A. ;
Olson, Eric N. .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04) :1222-1232
[4]   Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes [J].
Chen, XW ;
Zhang, XY ;
Kubo, H ;
Harris, DM ;
Mills, GD ;
Moyer, J ;
Berretta, R ;
Potts, ST ;
Marsh, JD ;
Houser, SR .
CIRCULATION RESEARCH, 2005, 97 (10) :1009-1017
[5]   Hypoadiponectinemia as a predictor for the development of hypertension - A 5-year prospective study [J].
Chow, Wing-Sun ;
Cheung, Bernard M. Y. ;
Tso, Annette W. K. ;
Xu, Aimin ;
Wat, Nelson M. S. ;
Fong, Carol H. Y. ;
Ong, Liza H. Y. ;
Tam, Sidney ;
Tan, Kathryn C. B. ;
Janus, Edward D. ;
Lam, Tai-Hing ;
Lam, Karen S. L. .
HYPERTENSION, 2007, 49 (06) :1455-1461
[6]   A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse [J].
Gao, Erhe ;
Lei, Yong Hong ;
Shang, Xiying ;
Huang, Z. Maggie ;
Zuo, Lin ;
Boucher, Matthieu ;
Fan, Qian ;
Chuprun, J. Kurt ;
Ma, Xin L. ;
Koch, Walter J. .
CIRCULATION RESEARCH, 2010, 107 (12) :1445-+
[7]   Calcium-mediated cell death during myocardial reperfusion [J].
Garcia-Dorado, David ;
Ruiz-Meana, Marisol ;
Inserte, Javier ;
Rodriguez-Sinovas, Antonio ;
Piper, Hans Michael .
CARDIOVASCULAR RESEARCH, 2012, 94 (02) :168-180
[8]   A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection [J].
Gomez, Ludovic ;
Paillard, Melanie ;
Price, Megan ;
Chen, Qun ;
Teixeira, Geoffrey ;
Spiegel, Sarah ;
Lesnefsky, Edward J. .
BASIC RESEARCH IN CARDIOLOGY, 2011, 106 (06) :1341-1353
[9]   Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin [J].
Holland, William L. ;
Miller, Russell A. ;
Wang, Zhao V. ;
Sun, Kai ;
Barth, Brian M. ;
Bui, Hai H. ;
Davis, Kathryn E. ;
Bikman, Benjamin T. ;
Halberg, Nils ;
Rutkowski, Joseph M. ;
Wade, Mark R. ;
Tenorio, Vincent M. ;
Kuo, Ming-Shang ;
Brozinick, Joseph T. ;
Zhang, Bei B. ;
Birnbaum, Morris J. ;
Summers, Scott A. ;
Scherer, Philipp E. .
NATURE MEDICINE, 2011, 17 (01) :55-U226
[10]   Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients [J].
Hotta, K ;
Funahashi, T ;
Arita, Y ;
Takahashi, M ;
Matsuda, M ;
Okamoto, Y ;
Iwahashi, H ;
Kuriyama, H ;
Ouchi, N ;
Maeda, K ;
Nishida, M ;
Kihara, S ;
Sakai, N ;
Nakajima, T ;
Hasegawa, K ;
Muraguchi, M ;
Ohmoto, Y ;
Nakamura, T ;
Yamashita, S ;
Hanafusa, T ;
Matsuzawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1595-1599